Live Breaking News & Updates on Epitranscriptomic Regulation
Stay updated with breaking news from Epitranscriptomic regulation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A STAR’s Genome Institute of Singapore , NanoString® Technologies, Inc. , and Next Level Genomics , today announced the establishment of a joint laboratory in Singapore focusing on the application. ....
E-Mail IMAGE: Eye of a patient with exfoliation syndrome. The typical white exfoliation material deposits on the surface of the lens are visible (red arrows) with the aid of a slit lamp. view more Credit: Agency for Science, Technology and Research (A STAR) s Genome Institute of Singapore,(GIS), Singapore Eye Research Institute (SERI) SINGAPORE - A team of researchers from the Agency for Science, Technology and Research s (A STAR) Genome Institute of Singapore (GIS) and Bioprocessing Technology Institute (BTI), as well as Singapore Eye Research Institute (SERI), have identified a genetic mutation (functionally defective CYP39A1 gene) associated with exfoliation syndrome, the most common cause of glaucoma. The findings could pave the way for future research on the cause of exfoliation syndrome and potential cures. Their research was published in Journal of the American Medical Association (JAMA) on 24 February 2021. ....
Singapore scientists develop novel gene editor to correct disease-causing mutations eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
Credit: A STAR s Genome Institute of Singapore (GIS) 22 December 2020, Singapore - For over 20 years, the Genetics Service at the KK Women s and Children s Hospital (KKH) has been providing clinical care to patients with genetic disorders. In 2014, BRIDGES (Bringing Research Innovations for the Diagnosis of GEnetic diseases in Singapore) was set up, in collaboration with genomic research institutes at SingHealth, Agency for Science, Technology and Research (A STAR) and Duke-NUS to synergise the diagnostic efforts and patient outcome management. After six years, the KKH has met the goals set out in its BRIDGES programme, achieving 39 per cent in diagnostic yield through identifying more patients with genetic mutations. This result is on par with similar research programmes globally which have a diagnostic yield of 25 to 40 per cent. ....